Finance entity

Jane Street Group LLC

Company

The clearest coverage concentration is earnings: 2 of 3 stories, with the rest divided among 1 other category. Of the tracked stories, 1 of 3 also mention Activest Wealth Management, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window.

Last mentioned: Aug 17, 2026

RSS updates
Share

Entity pulse

Recent coverage · Jane Street Group LLC

↑
3 stories
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Jane Street Group LLC

The clearest coverage concentration is earnings: 2 of 3 stories, with the rest divided among 1 other category. Of the tracked stories, 1 of 3 also mention Activest Wealth Management, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window. The 5 average consequence score is below the beat benchmark of 5.6 in the same window. Jane Street Group LLC appears in 3 tracked Finance stories published from August 15, 2026 through August 17, 2026.

Stories tracked
3
Sources per story
2

Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 80 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Jane Street Group LLC. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. STE trading level

    STERIS shares opened at $232.88, within a 52-week range of $195.14 to $269.44.

  2. Director Breeden insider sale

    STERIS director Richard C. Breeden sold 1,481 shares at an average price of $209.51, totaling $310,284.31 — a 3.66% reduction leaving 38,964 shares directly owned.

  3. Q2 2026 new positions

    Stoneridge Investment Partners initiated a new 4,497-share stake valued at $1,027,000. Elevation Wealth Partners raised its stake 1,130% to 123 shares ($26,000).

  4. Q1 2026 institutional accumulation

    Goldman Sachs lifted its position 32.3% to 242,732 shares ($55.0M). Jane Street increased 38.9% to 20,716 shares ($4.7M). Woodline Partners grew 40.0% to 8,300 shares ($1.88M). Jones Financial raised 46.1%. Empowered Funds added 16.1%. Geneos Wealth grew 416.0%. Western Wealth opened a new $25,000 stake.

  5. Q4 2025 13F filings

    Activest Wealth Management raised its STERIS stake 423.8% to 110 shares ($28,000), and Measured Wealth Private Client Group opened a new position valued at about $28,000.

Stories mentioning Jane Street Group LLC 3

Markets Neutral

Goldman Sachs Ups STERIS 32.3% as Institutions Own 94.69%

STERIS plc's latest 13F disclosures show a broad institutional accumulation wave: Goldman Sachs raised its stake 32.3% to 242,732 shares ($55M) in Q1, and Stoneridge Investment Partners opened a new $1.03M position in Q2. With 94.69% of the float owned by institutions and a director selling $310K of stock in June, the signals are mixed. Conservative leverage (debt-to-equity 0.23) and a 1.35 quick ratio support the long case.

2 sources

Source: tickerreport.com · dailypolitical.com

Earnings Neutral

MBRX Down 97% to $0.57 Despite EPS Beat: $22 Target Stale?

Moleculin Biotech shares rose 9.6% to $0.57 after a narrower-than-expected Q2 loss, yet the stock remains down roughly 97% from its 12-month high, with analysts' average $22.00 target detached from reality. The real signal for traders is a 2.3x volume surge, a beta of 1.83, and thin 15.52% institutional ownership.

2 sources
Earnings Neutral

Smith-Midland Posts $0.26 EPS, $23.36M Revenue; Shares Rise 1.7%

Smith-Midland's latest quarterly results show a profitable small-cap with an almost 20% return on equity and very low leverage, even as the stock trades about 35% below its 52-week high. The $0.26 EPS and $23.36 million revenue figure, combined with rising institutional holdings, make it a watch item for value-oriented small-cap investors. However, the stock remains below its 50-day and 200-day moving averages, keeping the technical picture cautious.

2 sources

Source: MarketBeat · themarketsdaily.com

Jane Street Group LLC is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.